Download PDF

1. Company Snapshot

1.a. Company Description

Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries – healthcare and real estate.As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population.For more than twenty years, Ventas has followed a successful strategy that endures: combining a high-quality diversified portfolio of properties and capital sources to manage through cycles, working with industry leading partners, and a collaborative and experienced team focused on producing consistent growing cash flows and superior returns on a strong balance sheet, ultimately rewarding Ventas shareholders.


As of September 30, 2020, Ventas owned or managed through unconsolidated joint ventures approximately 1,200 properties.

Show Full description

1.b. Last Insights on VTR

Ventas' recent momentum is driven by its expanding SHOP footprint, rising cash NOI, and active capital recycling. The company's strong Q4 FFO results, with higher FFO and revenues, were fueled by gains in SHOP and OM&R, offsetting a dip in triple-net results. According to Marketbeat, Ventas has earned an average recommendation of "Moderate Buy" from 17 research firms, with 14 analysts assigning a buy rating.

1.c. Company Highlights

2. Ventas' 2025 Earnings: A Strong Performance Driven by Senior Housing

Ventas reported a robust financial performance in 2025, with normalized FFO per share increasing by 9% and same-store SHOP cash net operating income growing by 15%. The company's earnings per share (EPS) came in at $0.89, in line with estimates. The strong performance was driven by its 1-2-3 strategy focused on senior housing, resulting in an enterprise value exceeding $50 billion. The fourth-quarter annualized NOI and SHOP NOI reached $2.5 billion and $1.3 billion, respectively.

Publication Date: Feb -09

📋 Highlights
  • Strong 2025 Performance:: Normalized FFO per share rose 9% to $3.78–$3.88 (2026 guidance), with same-store SHOP cash NOI up 15% to $1.3B.
  • Capital and Investment Activity:: Raised $7B in capital, closed $2.5B in senior housing investments, aiming for $2.5B in 2026, with $12B in unsettled equity for future funding.
  • 2026 Growth Outlook:: Expects 8% revenue growth driven by 7–8% in-house rent increases and 13–17% same-store SHOP NOI growth, with leverage near 5x.
  • High Occupancy and Margin Expansion:: SHOP same-store occupancy reached 90%, margins at 28%, with incremental margins of 50% expected in 2026, backed by $35B senior housing pipeline.
  • Strategic Positioning:: Outperforms via operator relationships, securing deals at or below replacement cost, and dynamic pricing via Ventas OI, despite rising competition and supply constraints.

Capital Raising and Investments

Ventas raised $7 billion in capital and closed $2.5 billion in high-quality senior housing investments in 2025. The company expects to continue this momentum in 2026, with guidance for $2.5 billion in senior housing investments. The acquisition pipeline is active, with $840 million already closed, and the company has high confidence in meeting its target.

2026 Guidance and Growth Expectations

Ventas guides for high single-digit growth in normalized FFO per share in 2026, led by SHOP, with expected normalized FFO per share in the range of $3.78 to $3.88. The company expects same-store SHOP NOI growth to be between 13% to 17%, driven by occupancy growth and RevPOR growth. Analysts estimate next year's revenue growth at 8.3%, driven by a 7-8% increase in in-house rent and some additional benefit from move-in rate growth.

Valuation and Leverage

With a P/E Ratio of 154.72 and an EV/EBITDA of 23.16, Ventas' valuation appears to be pricing in significant growth expectations. The company's leverage is approaching 5x, and it has $12 billion in unsettled equity to fund future investments. The Net Debt / EBITDA ratio stands at 5.65, indicating a moderate level of indebtedness.

Operational Highlights

The senior housing portfolio occupancy is 86% in the US, with minimal flu impacts and a strong sales cycle. The same-store SHOP occupancy rate has reached around 90%, with margins of around 28%. The company expects to see further margin expansion in 2026, with incremental margins in the 50% range. As Debra Cafaro noted, the senior population growth is expected to be 28% over the coming 5 years, driving demand for senior housing.

Dividend and Shareholder Returns

Ventas has increased its quarterly dividend by 8%, indicating a commitment to returning value to shareholders. The Dividend Yield stands at 2.33%, providing a relatively attractive income stream for investors.

3. NewsRoom

Card image cap

Ventas Stock Rallies 24.8% in Six Months: Will the Momentum Last?

Mar -06

Source: zacks.com

Card image cap

Focus Partners Advisor Solutions LLC Purchases 15,273 Shares of Ventas, Inc. $VTR

Mar -06

Source: defenseworld.net

Card image cap

Ventas, Inc. (VTR) Presents at 47th Annual Raymond James Institutional Investor Conference Transcript

Mar -04

Source: seekingalpha.com

Card image cap

Ventas, Inc. (VTR) Presents at Citi's Miami Global Property CEO Conference 2026 Transcript

Mar -03

Source: seekingalpha.com

Card image cap

Ventas Issues Investor Presentation for Upcoming Investor Conferences

Mar -02

Source: businesswire.com

Card image cap

Baron Real Estate Fund Q4 2025 Portfolio Activity

Mar -01

Source: seekingalpha.com

Card image cap

Ventas (NYSE:VTR) Hits New 12-Month High – Time to Buy?

Mar -01

Source: defenseworld.net

Card image cap

Ventas: An Investment-Grade Senior And Outpatient Care REIT That Just Keeps Growing

Feb -28

Source: seekingalpha.com

4. Business Breakdown

4.a. Revenues by Country

4.b. Revenues by Segment

5. Expected revenues mid-term growth (4.65%)

6. Segments

Senior Housing Operating Portfolio

Expected Growth: 4.5%

Ventas' Senior Housing Operating Portfolio growth of 4.5% is driven by increasing demand for senior living communities, driven by demographics (aging population), need for healthcare services, and rising acuity levels. Additionally, strategic partnerships, investments in technology, and operational efficiencies contribute to the growth.

Outpatient Medical and Research Portfolio

Expected Growth: 4.8%

Ventas' Outpatient Medical and Research Portfolio growth of 4.8% is driven by increasing demand for outpatient services, expansion of healthcare networks, and investments in medical research facilities. Additionally, the shift towards value-based care and aging population demographics contribute to the segment's growth.

Triple-Net Leased Properties

Expected Growth: 5.2%

Ventas, Inc.'s 5.2% growth in Triple-Net Leased Properties is driven by increasing demand for healthcare services, aging population, and strategic acquisitions. Additionally, the company's diversified portfolio, strong tenant credit, and long-term leases contribute to stable cash flows and growth. Furthermore, Ventas' focus on high-quality properties and proactive asset management also support the segment's growth.

Non-Segment

Expected Growth: 4.2%

Ventas, Inc.'s Non-Segment growth of 4.2% is driven by strategic investments in healthcare technology, expansion of medical office buildings, and increasing demand for senior housing. Additionally, the company's focus on diversifying its portfolio and strengthening its balance sheet has contributed to this growth.

7. Detailed Products

Senior Housing

Ventas, Inc. owns and operates senior housing communities that provide independent living, assisted living, and memory care services to seniors.

Medical Office Buildings

Ventas, Inc. owns and operates medical office buildings that provide healthcare services, including outpatient surgery, imaging, and physician practices.

Life Science Properties

Ventas, Inc. owns and operates life science properties that provide laboratory and research space for biotechnology, pharmaceutical, and medical device companies.

Hospital Investments

Ventas, Inc. owns and operates hospitals that provide acute care services, including emergency department, surgical, and rehabilitation services.

Outpatient Facilities

Ventas, Inc. owns and operates outpatient facilities that provide services such as ambulatory surgery, imaging, and physical therapy.

8. Ventas, Inc.'s Porter Forces

Forces Ranking

Threat Of Substitutes

Ventas, Inc. operates in a highly competitive industry, but the threat of substitutes is mitigated by the company's diversified portfolio of healthcare properties and its ability to adapt to changing market trends.

Bargaining Power Of Customers

Ventas, Inc.'s customers, primarily healthcare providers, have limited bargaining power due to the company's strong market position and the lack of alternative options for healthcare properties.

Bargaining Power Of Suppliers

Ventas, Inc. relies on a diverse range of suppliers for its operations, but the bargaining power of suppliers is moderate due to the company's scale and negotiating power.

Threat Of New Entrants

The threat of new entrants is low for Ventas, Inc. due to the high barriers to entry in the healthcare real estate industry, including significant capital requirements and regulatory hurdles.

Intensity Of Rivalry

The healthcare real estate industry is highly competitive, with several large players competing for market share, driving up the intensity of rivalry for Ventas, Inc.

9. SWOT Analysis

Strength

Weaknesses

Opportunities

Threats

10. Capital Structure

10.a. Balance Sheet

10.b. Weighted Average Cost of capital

Value
Debt Weight 58.71%
Debt Cost 4.72%
Equity Weight 41.29%
Equity Cost 10.21%
WACC 6.99%
Leverage 142.19%

11. Quality Control: Ventas, Inc. passed 2 out of 9 key points

12.a Historical Valuation

12.b Price/Earnings Ratio

12.c Margin Valuation

12.d Peers Valuation

Peers Group Analysis

Stock-Card
CareTrust REIT

A-Score: 7.1/10

Value: 2.5

Growth: 3.9

Quality: 8.3

Yield: 9.0

Momentum: 9.0

Volatility: 10.0

1-Year Total Return ->

View Full Report
Stock-Card
Omega Healthcare

A-Score: 6.9/10

Value: 2.9

Growth: 3.0

Quality: 7.3

Yield: 10.0

Momentum: 8.0

Volatility: 10.0

1-Year Total Return ->

View Full Report
Stock-Card
Sabra Health Care REIT

A-Score: 6.8/10

Value: 4.0

Growth: 3.4

Quality: 6.8

Yield: 10.0

Momentum: 7.0

Volatility: 9.7

1-Year Total Return ->

View Full Report
Stock-Card
Healthcare Realty Trust

A-Score: 6.4/10

Value: 5.9

Growth: 2.9

Quality: 5.4

Yield: 10.0

Momentum: 5.5

Volatility: 9.0

1-Year Total Return ->

View Full Report
Stock-Card
Medical Properties Trust

A-Score: 5.7/10

Value: 6.9

Growth: 0.9

Quality: 4.4

Yield: 10.0

Momentum: 8.0

Volatility: 4.0

1-Year Total Return ->

View Full Report
Stock-Card
Ventas

A-Score: 5.6/10

Value: 1.4

Growth: 3.6

Quality: 3.2

Yield: 7.0

Momentum: 9.0

Volatility: 9.7

1-Year Total Return ->

View Full Report

Peers Metrics

12.e Scoring Insights

12.f DCF BETA

Parameters

Short Term Growth

Short term Time

Long-Term Growth

WACC

Target Price

84.87$

Current Price

84.87$

Potential

-0.00%

Expected Cash-Flows